If you’ve started studying for the AANP or ANCC exam, you’ve probably already noticed the problem: pharmacology is everywhere. It’s not one contained section you can knock out and move on from — it’s woven into cardiology questions, endocrine questions, psych questions, even the OB section. You can’t skip it, and you can’t out-memorize it either.
The good news is that boards don’t actually test all of pharmacology. They test a fairly predictable set of drug classes, and within each class, they test the same handful of facts over and over — the interaction that’s dangerous, the monitoring parameter you can’t skip, the exception that trips people up. Once you know what those are, pharmacology stops feeling like an ocean and starts feeling like a list.
Here’s the breakdown, organized the way boards actually think about it — by body system, with the specific “if you only remember one thing about this drug class” fact for each.
Cardiovascular
This is one of the densest content areas on the exam, and for good reason — hypertension and cardiovascular disease management make up a huge share of primary care.
ACE inhibitors and ARBs. You need to know these cold, including the fact that they’re often taught together but tested on their differences. The cough is the classic ACE inhibitor side effect (bradykinin buildup), and it’s the reason to switch to an ARB — not stop treating the hypertension. Both carry hyperkalemia risk, and neither should ever be combined with the other.
Diuretics. The board-favorite distinction here is what each class does to potassium and calcium. Thiazides keep calcium (can worsen hypercalcemia) and lose potassium. Loop diuretics do the opposite on calcium — they waste it. If a question describes a patient on a diuretic with a calcium abnormality, this distinction is usually the answer.
Beta blockers. Know which three are proven to reduce mortality in heart failure with reduced ejection fraction: metoprolol succinate, carvedilol, and bisoprolol. This is one of those facts that seems oddly specific until you see it tested — and then you’ll see it again.
Psychiatric
Primary care NPs manage a lot of depression and anxiety, so this section is bigger than people expect going in.
SSRIs. The mechanism is simple, but the exam-worthy details are in the exceptions: citalopram’s dose-dependent QT prolongation, fluoxetine’s long half-life (which is why its discontinuation syndrome is milder and its washout period before an MAOI is longer), and the fact that full effect takes four to six weeks.
Serotonin syndrome. This deserves its own mental category, not just a bullet under SSRIs. It shows up from combining serotonergic drugs across completely different classes — an SSRI plus tramadol, plus a triptan, plus certain antibiotics. If a question describes autonomic instability, altered mental status, and neuromuscular findings like clonus, that’s the triad.
Endocrine
Insulin. You don’t need to memorize obscure formulations, but you do need the general onset/peak/duration pattern for rapid, short, intermediate, and long-acting insulin — and the fact that only regular insulin can be given IV, which matters for DKA management.
Metformin. The single most important fact: it doesn’t cause hypoglycemia on its own, which is exactly why it gets compared against sulfonylureas (which do) on exam questions. Also know to hold it around IV contrast.
Antibiotics
This section rewards pattern recognition more than memorization. A few load-bearing facts:
• Fluoroquinolones carry black box warnings for tendon rupture — this alone is often the “why wouldn’t you choose this drug” answer.
• Tetracyclines are contraindicated in pregnancy and in children under eight because of tooth discoloration.
• Sulfa drugs (like TMP-SMX) require checking for sulfa allergy and G6PD deficiency.
The Pattern Behind All of It
Notice something about every example above: it’s never just “here’s what the drug does.” It’s the exception — the interaction, the contraindication, the monitoring requirement — that makes a fact testable. Boards aren’t interested in whether you can recite a mechanism of action. They’re interested in whether you’ll catch the dangerous combination or the red-flag symptom in a clinical scenario.
That’s really the whole game with pharmacology on the FNP boards: learn the mechanism once, quickly, and then spend your actual study time on the gotchas.
How to Actually Study This
A few things that make a real difference:
Group by comparison, not by drug. Studying ACE inhibitors in isolation is less useful than studying them side-by-side with ARBs, since that’s how they’re tested — as a distinction, not a standalone fact.
Study the cross-cutting concepts separately. Serotonin syndrome, drug-induced hyperkalemia, opioid overdose recognition — these span multiple drug classes and deserve their own review pass, because they’re exactly the kind of “connect the dots” thinking boards are testing for.
Don’t reread your pharm textbook. This is the biggest time sink students describe after the fact. A 900-page textbook wasn’t written for boards — it was written to teach pharmacology as a discipline, which means a lot of detail that will never appear on your exam. A tighter, exam-focused reference gets you through the material faster and leaves more study time for practice questions, which is where the actual learning happens.
If you want all of this compiled into one place — every drug class above, plus the comparison tables and the specific “board gotcha” for each one, organized by body system — that’s exactly what I built the FNP Pharmacology Quick Reference for. It’s the reference I wish existed when I was studying: 31 pages, no fluff, just the facts that show up on test day.
Whatever you study from, good luck — you’ve got this.